Project Grant R24OD039767
- The National Institute of Environmental Health Sciences, an office within the Department of Health and Human Services National Institutes of Health, awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $353,250 on August 1, 2026, under the Medical Library Assistance program (CFDA 93.879) to develop novel computational methods for analyzing gene regulatory networks and massively parallel reporter assay data in a cell-type-specific manner. The project...
- The National Institute of General Medical Sciences awarded Rutgers, The State University of New Jersey $533,456 on July 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to support research on regulation of PIEZO2 and TRPV6/5 ion channels. The funded research defines the molecular basis of phosphatidic acid and lysophosphatidic acid inhibition of the mechanically-activated PIEZO2 ion channel and interrogates how phospholipase-D and diacylglycerol-kinase...
- The National Institutes of Health Office of the Director awarded the University of Delaware $349,827 on August 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to procure and install individually ventilated caging (IVC) systems and filtered animal handling transfer cabinets at the Life Sciences Research Facility (LSRF) in Newark, Delaware. The LSRF, which serves over 30 principal investigators and multiple NIH-funded programs, has experienced 70 percent growth in animal housing...
- The National Institute of General Medical Sciences awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $321,304 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing R35GM162265) to conduct research on the metabolic regulation of innate immunity-dependent wound healing in situ. The research employs zebrafish (Danio rerio) as an in vivo model to dissect multi-cellular interactions during tissue...
- The National Institute of General Medical Sciences awarded Rutgers The State University of New Jersey $431,750 on July 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support five years of research on internal N7-methylguanosine (m7G) modification in RNA metabolism through September 30, 2031. The research investigates how internal m7G—a recently discovered RNA modification positioned within mRNA transcript bodies—regulates RNA metabolism and gene...
- The National Institute of Neurological Disorders and Stroke awarded Rutgers, The State University $118,593 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing). The award funds research investigating the role of dorsal horn interneurons expressing the serotonin 6 receptor (5HTR6+ interneurons) in sensorimotor integration within the spinal cord under both normal conditions and following spinal cord...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $642,253 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct high-precision mapping of sex hormone modulation of reward value computations in opioid addiction. The research addresses disparities in medications for opioid use disorder treatment, which fails in a sizable proportion of patients, particularly female patients...
- The National Institute of General Medical Sciences awarded Rutgers, The State University $383,511 on August 1, 2026, as a Project Grant (CFDA 93.859, Biomedical Research and Research Training) to investigate microbial modulation of insect sensory plasticity. The research establishes a framework for understanding how microbes and microbial products regulate insect sensory plasticity and how these interactions are influenced by environmental context and microbial metabolites. The work integrates...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $811,772 on June 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to identify drug tolerance mechanisms in Mycobacterium tuberculosis glpK mutants and develop improved treatments for drug-tolerant persister bacilli. The research uses an MTB H37RV glpK knockout strain to determine genes and genetic pathways...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $2.060 million on September 11, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate host-bacterial interactions determining the spectrum of Mycobacterium tuberculosis transmission. The research examines the biology of MTB infection across exposed household contacts and "resister"...
The National Institutes of Health Office of the Director awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $398,640 under Project Grant R24OD039767 on September 1, 2026, to examine the effects of caging density, temperature, and cage-change frequency on the rigor and reproducibility of research conducted with mouse models. The recipient will employ home cage monitoring, video recording, ultrasonic vocalization recording, and telemetry to assess how these three extrinsic variables affect the physiology and behavior of mice over three months. This novel monitoring approach will be compared against traditional behavioral assessment methods including open field, elevated maze, and water maze tests. The study uses genetically modified animal models of human disease to identify physiological mechanisms and specific brain regions—particularly the ventromedial hypothalamus—that mediate the effects of these variables and their impact on research rigor and reproducibility. The comprehensive evaluation will generate a dataset intended to help the mouse research community refine experimental design, analysis, reporting, and reproducibility across projects funded by multiple NIH institutes including the National Institute of Mental Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, and National Institute of General Medical Sciences. Performance occurs in Newark, New Jersey. The award runs through May 31, 2030. This is a Project Grant under the Research Infrastructure Programs (CFDA 93.351) program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $398.6k | 8/24/26 |